Drugmaker GSK profit rockets on consumer health spinoff | ABS-CBN

ADVERTISEMENT

dpo-dps-seal
Welcome, Kapamilya! We use cookies to improve your browsing experience. Continuing to use this site means you agree to our use of cookies. Tell me more!

Drugmaker GSK profit rockets on consumer health spinoff

Drugmaker GSK profit rockets on consumer health spinoff

Agence France-Presse

Clipboard

EPA-EFE/OLIVIER HOSLET
The vaccines production center of GlaxoSmithKline (GSK) in Wavre, Belgium, 03 February 2021. GSK announced earlier today it will support CureVac in the manufacture of up to 100 million doses at its Wavre production site. EPA-EFE/OLIVIER HOSLET

LONDON - British drugmaker GlaxoSmithKline said Wednesday that third-quarter net profit rocketed almost ten-fold to £10.3 billion ($11.5 billion) on the blockbuster spinoff of consumer healthcare division Haleon.

Earnings after taxation spiked in the three months to the end of September from a year earlier, due to a total gain of £9.6 billion on the Haleon demerger, GSK said in a results statement.

RELATED VIDEO:

Watch more News on iWantTFC

ADVERTISEMENT

ADVERTISEMENT

It looks like you’re using an ad blocker

Our website is made possible by displaying online advertisements to our visitors. Please consider supporting us by disabling your ad blocker on our website.

Our website is made possible by displaying online advertisements to our visitors. Please consider supporting us by disabling your ad blocker on our website.